|
Immunology (including allergy)
Citations 3141-3150 of 40050 total displayed.
|
Past content
(since Oct 1840):
|
-
- News
- GlaxoSmithKline denies it has settled thousands of lawsuits over rosiglitazone (Avandia)
- Janice Hopkins Tanne
-
BMJ 2010;340:c3010, doi: 10.1136/bmj.c3010,
-
[Extract]
[Full text]
-
- Head to Head
- Should the Quality and Outcomes Framework be abolished? No
- A Niroshan Siriwardena
-
BMJ 2010;340:c2794, doi: 10.1136/bmj.c2794,
-
[Extract]
[Full text]
-
- News
- Australian government says healthy under 5s should not be given seasonal flu jab
- Ray Moynihan
-
BMJ 2010;340:c2991, doi: 10.1136/bmj.c2991,
-
[Extract]
[Full text]
-
- Analysis
- Multiple sclerosis risk sharing scheme: a costly failure
- James Raftery
-
BMJ 2010;340:c1672, doi: 10.1136/bmj.c1672,
-
[Extract]
[Full text]
-
- Analysis
- Continuing the multiple sclerosis risk sharing scheme is unjustified
- Christopher McCabe, Jim Chilcott, Karl Claxton, Paul Tappenden, Cindy Cooper, Jennifer Roberts, Nicola Cooper, and Keith Abrams
-
BMJ 2010;340:c1786, doi: 10.1136/bmj.c1786,
-
[Extract]
[Full text]
-
- Analysis
- Commentary: Outcome measures were flawed
- G C Ebers
-
BMJ 2010;340:c2693, doi: 10.1136/bmj.c2693,
-
[Extract]
[Full text]
-
- Analysis
- Commentary: Scheme has benefited patients
- Alastair Compston
-
BMJ 2010;340:c2707, doi: 10.1136/bmj.c2707,
-
[Extract]
[Full text]
-
- Editorials
- The multiple sclerosis risk sharing scheme
- Neil Scolding
-
BMJ 2010;340:c2882, doi: 10.1136/bmj.c2882,
-
[Extract]
[Full text]
-
- Editorials
- A moment of truth for global health
- Richard Feachem, Gavin Yamey, and Christina Schrade
-
BMJ 2010;340:c2869, doi: 10.1136/bmj.c2869,
-
[Extract]
[Full text]
-
- Editorials
- Oral immunotherapy for peanut allergy
- Aziz Sheikh, Iris Venderbosch, and Ulugbek Nurmatov
-
BMJ 2010;340:c2938, doi: 10.1136/bmj.c2938,
-
[Extract]
[Full text]
|